ARNI Versus Perindopril for Remodeling in HFrEF. A Cohort Study
Introduction: Ventricular remodeling is a mal-adaptive process. Both angiotensin-converting enzyme inhibitors and sacubitril/valsartan have been shown to reverse remodeling in mostly uncontrolled observational studies. There is a lack of head-to-head studies. Methods: This cohort study compares the...
Saved in:
Main Authors: | Noor Muhammad Azlan Shah Bin Atan MBBS (Author), Mohd Firdaus Bin Hadi MBBS (Author), Victoria Wen Yeng Teoh (Author), Mahmoud Danaee PhD (Author), Alexander Loch MBBS, MRCP, MCEM, MD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Astragalus membranaceus on left ventricular remodeling in HFrEF: a systematic review and meta-analysis
by: Xu Han, et al.
Published: (2024) -
Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)
by: Przemysław Żelazny, et al.
Published: (2022) -
The Inflammation-Fibrosis Combined Index: A Novel Marker for Predicting Left Ventricular Reverse Remodeling and Prognosis in Patients with HFrEF
by: Shi J, et al.
Published: (2024) -
Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
by: Qian Xiang, et al.
Published: (2022) -
The effect of 4 weeks of virtual reality, interval nordic walking and ambient music interventions on cardiorespiratory recovery in the elderly patients with HFrEF in response to cardiopulmonary exercise test
by: Ardavan Taheri, et al.
Published: (2024)